<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28928" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Serum Myoglobin</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zafar Gondal</surname>
            <given-names>Anoosh</given-names>
          </name>
          <aff>Rawal Institute of Health Sciences</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Foris</surname>
            <given-names>Lisa A.</given-names>
          </name>
          <aff>St. George's University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zubair</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>Indus Hospital &#x00026; Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Richards</surname>
            <given-names>John R.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anoosh Zafar Gondal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Lisa Foris declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Zubair declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Richards declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28928.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Myoglobin is a dark red cytoplasmic hemoprotein found only in cardiac myocytes and oxidative skeletal muscle fibers.<xref ref-type="bibr" rid="article-28928.r1">[1]</xref> It belongs to the super globin family of proteins. It comprises a single polypeptide chain of 154 amino acids and a porphyrin ring containing a central ferrous iron molecule. Similar to hemoglobin, myoglobin functions to reversibly bind oxygen and can form oxymyoglobin, carboxy myoglobin, or metmyoglobin.<xref ref-type="bibr" rid="article-28928.r2">[2]</xref> Unlike hemoglobin, however, myoglobin has only one binding site for oxygen, the affinity of which is comparatively&#x000a0;very high.<xref ref-type="bibr" rid="article-28928.r3">[3]</xref>&#x000a0;As a result, myoglobin can receive oxygen from hemoglobin at the tissue level via the Bohr effect and either store oxygen or deliver it to muscle cells during periods of hypoxia, anoxia, or increased metabolic activity.<xref ref-type="bibr" rid="article-28928.r4">[4]</xref></p>
      </sec>
      <sec id="article-28928.s2" sec-type="Etiology and Epidemiology">
        <title>Etiology and Epidemiology</title>
        <p>Due to its low molecular weight, myoglobin is released quickly following muscle injury; it is the earliest marker of myocardial infarction and rhabdomyolysis.<xref ref-type="bibr" rid="article-28928.r5">[5]</xref> The release of myoglobin from muscles during such conditions is often also associated with the release of lactate dehydrogenase (LDH), creatine kinase, and serum glutamic-pyruvic transaminase, in addition to other enzymes.<xref ref-type="bibr" rid="article-28928.r6">[6]</xref> Secondary complications of rhabdomyolysis include hyperkalemia, hypocalcemia, and acute kidney injury; myoglobin in the urine is toxic to the nephron.<xref ref-type="bibr" rid="article-28928.r7">[7]</xref></p>
        <p>Myoglobinuria in adults is most often encountered in cases of alcohol and drug abuse or trauma; muscle necrosis with subsequent myoglobin release also commonly occurs due to prolonged immobilization or pressure from the weight of the body.<xref ref-type="bibr" rid="article-28928.r8">[8]</xref>&#x000a0;Furthermore, excessive physical activity; metabolic disorders; viral infections, such as influenza, HIV, or herpes simplex; toxin-producing bacterial infections; connective tissue disease; seizures; electrical shock injury, including lightning strikes; third-degree burns; venom from a snake or insect bite; certain medications, such as statins or antipsychotics; or prolonged alcohol or drug use, as with heroin, cocaine, or amphetamines all&#x000a0;can&#x000a0;create an imbalance in muscle energy production and consumption which result in muscle damage and destruction.<xref ref-type="bibr" rid="article-28928.r9">[9]</xref></p>
        <p>Contrastingly, rhabdomyolysis or myoglobinuria in children is often associated with viral myositis, trauma, excessive muscular exertion, drug overdose, seizures, connective tissue&#x000a0;disease, or metabolic disorders.<xref ref-type="bibr" rid="article-28928.r10">[10]</xref></p>
        <p>The incidence of myoglobinuria in the United States varies depending on the incidence of traumas or natural disasters. An increased incidence of viral myositis, such as that caused by a regional epidemic, may cause a temporary increase in the incidence of rhabdomyolysis and myoglobinuria.<xref ref-type="bibr" rid="article-28928.r11">[11]</xref>&#x000a0;The excessive heat or higher temperatures&#x000a0;seen in the summer months or warmer geographic areas may cause heat stroke, especially in those who are more active; malignant hyperthermia or neuroleptic malignant syndrome may additionally increase the incidence of stress or exertion-induced rhabdomyolysis.<xref ref-type="bibr" rid="article-28928.r12">[12]</xref></p>
      </sec>
      <sec id="article-28928.s3" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Under normal conditions, myoglobin circulates in the blood bound to plasma globulins which are maintained between 0 to 0.003 mg/dL.<xref ref-type="bibr" rid="article-28928.r7">[7]</xref> Once serum myoglobin levels reach a level above 0.5 to 1.5 mg/dL, the rate of metabolism, endocytosis, and serum protein binding capacity is overwhelmed, and myoglobin is rapidly excreted in the urine.<xref ref-type="bibr" rid="article-28928.r13">[13]</xref></p>
        <p>Myoglobin release from muscle tissues occurs due to damage to muscle cells and a change in skeletal muscle cell membrane permeability.<xref ref-type="bibr" rid="article-28928.r14">[14]</xref> Damage to muscle cells results in dysregulation of sodium-calcium channel functioning, ultimately elevating intracellular free ionized calcium.<xref ref-type="bibr" rid="article-28928.r15">[15]</xref> This causes a resultant activation of calcium-dependent enzymes, which&#x000a0;further metabolize and destroy the muscle cell membrane and allow for the release of intracellular contents, including myoglobin and creatine kinase.<xref ref-type="bibr" rid="article-28928.r16">[16]</xref></p>
        <p>In health, myoglobin is easily filtered by the glomerulus and quickly excreted in the urine. However, large amounts of myoglobin in renal tubules can lead to an interaction of the hemoprotein with Tamm-Horsfall proteins, subsequent precipitation, and tubular obstruction.<xref ref-type="bibr" rid="article-28928.r17">[17]</xref> This process occurs most favorably in conditions where acidic urine is present.&#x000a0;In addition, damage to both muscle tissues and kidney epithelial cells promotes the production of reactive oxygen species, which can, in turn, lead to the oxidation of ferrous oxide to ferric oxide, a hydroxyl radical.<xref ref-type="bibr" rid="article-28928.r18">[18]</xref>&#x000a0;Myoglobinuria-induced tubular obstruction and oxidative damage can, either alone or in combination, lead to acute kidney injury.<xref ref-type="bibr" rid="article-28928.r19">[19]</xref></p>
      </sec>
      <sec id="article-28928.s4" sec-type="Specimen Requirements and Procedure">
        <title>Specimen Requirements and Procedure</title>
        <p>The preferred specimen is non-hemolyzed, non-lipemic serum. One study found no significant difference between heparinized plasma and serum, although results from EDTA plasma samples were significantly lower than serum samples.<xref ref-type="bibr" rid="article-28928.r20">[20]</xref> Another study found that different anticoagulants can substantially interfere with myoglobin assays.<xref ref-type="bibr" rid="article-28928.r21">[21]</xref> Each method should be investigated concerning the differences observed between serum and the use of various anticoagulants.&#x000a0;Specimens are stable at 4^oC for one week and up to four weeks at &#x02212;20^oC.<xref ref-type="bibr" rid="article-28928.r22">[22]</xref></p>
        <p>Urine samples should be collected without preservatives and assayed within 24 hours of sample collection. If the test is not performed immediately after sample collection, the urine sample should be kept at 2^oC to 8^oC and centrifuged to remove any debris before the assay.<xref ref-type="bibr" rid="article-28928.r23">[23]</xref> Myoglobin in urine is stable under alkaline conditions (pH 9.0) for many days at 2^oC, &#x02212;20^oC, and &#x02212;70^oC; sodium hydroxide can be added if long-term storage is needed.<xref ref-type="bibr" rid="article-28928.r24">[24]</xref></p>
      </sec>
      <sec id="article-28928.s5" sec-type="Diagnostic Tests">
        <title>Diagnostic Tests</title>
        <p>The diagnosis of rhabdomyolysis requires a&#x000a0;high index of suspicion, given that the classic clinical symptoms may not be present.<xref ref-type="bibr" rid="article-28928.r7">[7]</xref> A definitive diagnosis is often made by elevated serum creatine kinase or urine myoglobin.<xref ref-type="bibr" rid="article-28928.r25">[25]</xref>&#x000a0;Liver and renal function may be assessed if complications secondary to rhabdomyolysis are concerning.<xref ref-type="bibr" rid="article-28928.r26">[26]</xref>&#x000a0;</p>
        <p>Although myoglobin is the first enzyme to be elevated in rhabdomyolysis, levels often return to normal within 24 hours after the onset of symptoms.<xref ref-type="bibr" rid="article-28928.r27">[27]</xref> Serum creatine kinase levels, on the other hand, begin to rise approximately 2 to 12 hours after the onset of symptoms and remain elevated for 7 to 10 days, with levels peaking around three days after the onset of symptoms.<xref ref-type="bibr" rid="article-28928.r28">[28]</xref> Serum creatine kinase is also an important and useful tool for gauging the severity of rhabdomyolysis.<xref ref-type="bibr" rid="article-28928.r29">[29]</xref>&#x000a0;Elevated serum creatine kinase suggests a possible delay of clearance from the plasma by the kidneys, indicating complications such as acute kidney damage or injury.<xref ref-type="bibr" rid="article-28928.r30">[30]</xref></p>
        <p>Though myoglobinuria is pathognomonic for rhabdomyolysis, it is important to note that rhabdomyoglobinuria is not always present or visible.<xref ref-type="bibr" rid="article-28928.r31">[31]</xref>&#x000a0;The presence of myoglobin in the blood also lacks cardiac specificity due to its concomitant expression in both cardiac and skeletal muscle cells.<xref ref-type="bibr" rid="article-28928.r32">[32]</xref> Therefore, a more specific indicator, such as troponin or creatine kinase, must be measured to confirm a diagnosis of acute myocardial infarction.<xref ref-type="bibr" rid="article-28928.r33">[33]</xref><bold>&#x000a0;</bold></p>
        <p>Urinalysis should be employed to evaluate for myoglobinuria and assess the presence or severity of renal damage or acute kidney injury.<xref ref-type="bibr" rid="article-28928.r34">[34]</xref> Furthermore, if kidney injury due to rhabdomyolysis is suspected, the serum creatinine level should be assessed; creatinine is often quickly elevated during rhabdomyolysis when compared to other causes of kidney injury. In addition to this, the blood urea nitrogen to creatinine ratio is also generally low.<xref ref-type="bibr" rid="article-28928.r35">[35]</xref></p>
        <p>A thorough history and physical examination are critical to diagnosing rhabdomyolysis, though they are not always helpful in determining the underlying cause.<xref ref-type="bibr" rid="article-28928.r25">[25]</xref> If infectious causes are suspected, one should assess the complete blood count, appropriate cultures, and any additional serologic studies that may help confirm or point toward a diagnosis. Blood chemistries and endocrine assays may be helpful if an underlying endocrine abnormality is suspected.<xref ref-type="bibr" rid="article-28928.r26">[26]</xref> If drugs or toxins are a potential underlying cause, the appropriate screening for toxins should be performed.<xref ref-type="bibr" rid="article-28928.r36">[36]</xref> In patients with repeated instances of rhabdomyolysis, genetic testing, a muscle biopsy, or the forearm ischemic exercise test may reveal an underlying myopathy or metabolic disorder.<xref ref-type="bibr" rid="article-28928.r28">[28]</xref></p>
        <p>Though imaging is not generally indicated in cases of rhabdomyolysis, given that it is a clinical syndrome often diagnosed with supportive laboratory tests, MRI, bone scintigraphy, ultrasound, or CT can be used to demonstrate some changes in muscle tissue.<xref ref-type="bibr" rid="article-28928.r37">[37]</xref> An ECG is necessary to detect cardiac arrhythmias from electrolyte abnormalities due to rhabdomyolysis.<xref ref-type="bibr" rid="article-28928.r38">[38]</xref> An assessment of blood chemistries&#x000a0;also&#x000a0;may help point towards this, in addition to an arterial blood gas analysis if metabolic acidosis is suspected.<xref ref-type="bibr" rid="article-28928.r25">[25]</xref></p>
      </sec>
      <sec id="article-28928.s6" sec-type="Testing Procedures">
        <title>Testing Procedures</title>
        <p>Qualitative and semiquantitative immunological methods have been used for the detection of myoglobin.<xref ref-type="bibr" rid="article-28928.r24">[24]</xref> With the simplicity of the agar gel precipitin techniques and the speed of electrophoresis, counter immunoelectrophoresis has been used to detect myoglobin in both serum and urine.<xref ref-type="bibr" rid="article-28928.r39">[39]</xref> It&#x000a0;is a qualitative procedure with a sensitivity of only 2 mg/L. Thus, it is unsuitable for detecting acute myocardial infarction (AMI).<xref ref-type="bibr" rid="article-28928.r40">[40]</xref></p>
        <p>A rapid, qualitative latex agglutination test for detecting increased concentrations of myoglobin in serum has been reported.<xref ref-type="bibr" rid="article-28928.r41">[41]</xref> In this test procedure, any interfering rheumatoid factor present in the sample is removed when 50 &#x003bc;L of test serum is mixed with 5 &#x003bc;L of rheumatoid factor absorption medium on a dark slide. About 50 &#x003bc;L of a suspension of latex particles with bound anti-myoglobin antibodies is added and mixed with the serum by gentle tilting for 5 minutes. Agglutination of the particles occurs in the presence of myoglobin. A negative exponential relationship has been found between the time of agglutination and myoglobin concentrations.<xref ref-type="bibr" rid="article-28928.r42">[42]</xref> Myoglobin concentration was considered to be greater than 400 mg/L if agglutination occurred within 1 minute, 150 to 400 mg/L if agglutination time was between 1 and 2 minutes, 80 to 150 mg/L if agglutination time was between 2 and 3 minutes, and less than 80 mg/L (upper limit of reference interval) if more than 3 minutes were required for agglutination.<xref ref-type="bibr" rid="article-28928.r43">[43]</xref></p>
        <p>Red blood cell agglutination techniques are reported to be sensitive in the 50 to 100 mg/L range.&#x000a0;A disadvantage of this technique is that some sera containing a high concentration of rheumatoid factor gave positive agglutination reactions.<xref ref-type="bibr" rid="article-28928.r44">[44]</xref> The latex&#x000a0;agglutination procedure is, at best semiquantitative and is somewhat subjective, requiring visual observation to establish an endpoint. The sensitivity of the latex test may not be adequate.<xref ref-type="bibr" rid="article-28928.r45">[45]</xref> The advantage of the latex test is its simplicity.<xref ref-type="bibr" rid="article-28928.r42">[42]</xref></p>
        <p>A quantitative microcomplement fixation assay has been developed to detect myoglobin in the serum and urine of patients with acute coronary syndrome or myopathies.<xref ref-type="bibr" rid="article-28928.r46">[46]</xref> This technique is based on consuming a fixed amount of hemolytic complement by myoglobin-antimyoglobin complexes.<xref ref-type="bibr" rid="article-28928.r47">[47]</xref> The amount of myoglobin present in the sample is inversely proportional to the extent of hemolysis of the hemolysin-sensitized sheep cells used as the indicator system.<xref ref-type="bibr" rid="article-28928.r48">[48]</xref> Quantitative microcomplement fixation is an extremely time-consuming and laborious technique.<xref ref-type="bibr" rid="article-28928.r47">[47]</xref>&#x000a0;</p>
        <p>Currently, the determination of serum myoglobin for diagnosing AMI and other muscle disorders is performed almost exclusively by immunoassay techniques because of their high analytical sensitivity, specificity, precision, and rapid turnaround time.<xref ref-type="bibr" rid="article-28928.r49">[49]</xref> Radioimmunoassay (RIA) procedures have also been described for quantitative measurement of serum myoglobin. However, in clinical laboratories, RIA has largely been replaced by automated 2-site non-isotopic immunoassays.<xref ref-type="bibr" rid="article-28928.r50">[50]</xref> The capture antibody is linked to a bead or paramagnetic particle. The detecting antibody is linked to a tag that can produce a nephelometric, turbidimetric, fluorometric, or chemiluminescence signal.<xref ref-type="bibr" rid="article-28928.r49">[49]</xref> Automated immunoassay analyzers perform a separation between bound and free labels to produce a quantitative result.<xref ref-type="bibr" rid="article-28928.r51">[51]</xref>&#x000a0;</p>
        <p>Qualitative and quantitative methods for serum myoglobin have also been developed for point-of-care (POC) use.<xref ref-type="bibr" rid="article-28928.r52">[52]</xref> One POC method utilizes a self-calibrating immunoassay system whereby whole blood is separated from plasma that reacts with fluorescent antibody conjugates within a reaction chamber. Following an incubation step, the reaction mixture flows down a detection lane by capillary action. The myoglobin&#x02013;fluorescent antibody complex is captured by a second antibody in a discrete measuring zone. The intensity of the label (visual or fluorescence) is related to myoglobin concentration. The procedure takes approximately 15 minutes to complete.<xref ref-type="bibr" rid="article-28928.r53">[53]</xref> Since myoglobin measurements are most commonly used in diagnosing and excluding AMI, several POC devices have combined myoglobin with other cardiac markers, such as CK-MB and cardiac troponin, into a single cartridge or slide.<xref ref-type="bibr" rid="article-28928.r54">[54]</xref></p>
        <p>International guidelines such as those from the National Academy of Clinical Biochemistry have suggested that results of cardiac markers should be reported within one hour of blood collection.<xref ref-type="bibr" rid="article-28928.r55">[55]</xref> Other groups, such as the American Heart Association, have suggested an optimal turnaround time of under 30 minutes.<xref ref-type="bibr" rid="article-28928.r56">[56]</xref> These POC devices are designed for use at the patient bedside or emergency department satellite laboratories to produce results that meet these recommended 30- to 60-minute turnaround time goals for reporting test results.<xref ref-type="bibr" rid="article-28928.r57">[57]</xref></p>
      </sec>
      <sec id="article-28928.s7" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>The use of collection tubes with separator gels has been reported to both increase and decrease myoglobin results.<xref ref-type="bibr" rid="article-28928.r21">[21]</xref>&#x000a0; Bilirubin has been found not to interfere.<xref ref-type="bibr" rid="article-28928.r58">[58]</xref> Rheumatoid factor (RF) has been found to affect results in some assays, with a lack of concordance between concentrations of RF and the magnitude of interference.<xref ref-type="bibr" rid="article-28928.r49">[49]</xref> As with any 2-site immunoassays that use monoclonal antibodies, the presence of human anti-mouse antibodies can potentially cause a false-positive result.<xref ref-type="bibr" rid="article-28928.r59">[59]</xref></p>
      </sec>
      <sec id="article-28928.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Myoglobin is a relatively small globular protein composed of a single polypeptide chain of 154 amino acids and an iron-containing heme prosthetic group identical to that of hemoglobin.<xref ref-type="bibr" rid="article-28928.r11">[11]</xref>&#x000a0;It can reversibly bind oxygen molecules and speed up the diffusion of oxygen into skeletal and cardiac muscle cells, where it is present.<xref ref-type="bibr" rid="article-28928.r1">[1]</xref> Myoglobin is an oxygen carrier in the cytoplasm and appears responsible for transporting oxygen from the muscle cell membrane to the mitochondrion.<xref ref-type="bibr" rid="article-28928.r60">[60]</xref> Immunological techniques cannot discriminate between myoglobins from skeletal and cardiac muscles since they are immunologically identical.<xref ref-type="bibr" rid="article-28928.r46">[46]</xref></p>
        <p>Due to its relatively low molecular mass, myoglobin may leak from muscle tissue into the bloodstream due to skeletal or cardiac muscle injury and then show up in the urine.<xref ref-type="bibr" rid="article-28928.r8">[8]</xref>&#x000a0;Myoglobinemia and myoglobinuria have been used in the diagnosis of myopathies and cardiomyopathies.<xref ref-type="bibr" rid="article-28928.r28">[28]</xref> A pronounced increase in serum myoglobin is an early quantitative indicator of AMI.<xref ref-type="bibr" rid="article-28928.r5">[5]</xref> It has been reported that myoglobinuria is a more sensitive clinical indicator of AMI than increased activities or concentrations of serum creatine kinase-MB (CK-MB) isoenzyme, especially when blood samples are drawn in the early stage of the disease (e.g., within 3 hours after onset).<xref ref-type="bibr" rid="article-28928.r61">[61]</xref> However, these assays are less specific because no assay can differentiate myocardial from skeletal muscle myoglobin.<xref ref-type="bibr" rid="article-28928.r62">[62]</xref> Increased serum myoglobin concentrations return to normal sooner than&#x000a0;total CK and the CK-MB isoenzyme in AMI.<xref ref-type="bibr" rid="article-28928.r63">[63]</xref> The faster elimination of myoglobin from the blood may be advantageous in the assessment of reinfarctions occurring during the period of increased enzyme activities.<xref ref-type="bibr" rid="article-28928.r64">[64]</xref> Recurrent increases in serum myoglobin are thus suggestive of an extension of the original infarction.<xref ref-type="bibr" rid="article-28928.r65">[65]</xref></p>
        <p>Since myoglobin is also present in skeletal muscle and is cleared almost exclusively through glomerular filtration, myoglobin will increase after acute muscle trauma, acute or chronic kidney injury, severe heart failure, prolonged shock, and in patients with myopathies of a variety of causes.<xref ref-type="bibr" rid="article-28928.r11">[11]</xref> Therefore, using serum myoglobin levels to furnish early, quantitative documentation of AMI should be limited to patients who do not have these underlying or associated problems and who are within the first 18 hours of the clinical onset of infarction.</p>
        <p>In addition, serum myoglobin levels have been used to evaluate neuromuscular diseases such as muscular dystrophy, muscular atrophy, and polymyositis.<xref ref-type="bibr" rid="article-28928.r66">[66]</xref> Percy et al. reported that the combination of CK, hemopexin, and myoglobin measurements provided significantly better detection of Duchenne muscular dystrophy carriers than when these three tests were used alone or as a combination of CK and hemopexin without myoglobin.<xref ref-type="bibr" rid="article-28928.r67">[67]</xref></p>
        <p>In studies conducted on myopathies in children, serum myoglobin concentrations for subjects 0.6 to 20 years were lower than in adults, so using assays with a high sensitivity of 2 &#x000b5;g/L or less is necessary.<xref ref-type="bibr" rid="article-28928.r68">[68]</xref> Mean myoglobin concentrations of 17.1 and 12.5 &#x000b5;g/L were obtained from 37 males and 29 females, respectively, and were statistically different.</p>
        <p>Investigations in children with muscle diseases, however, have been somewhat disappointing. Only 2 out of 14 patients studied had increased serum myoglobin concentrations. The patients evaluated in this study were relatively young, ranging from 0.3 to 16 years of age, and were presumably in the relatively early stages of the disease.<xref ref-type="bibr" rid="article-28928.r66">[66]</xref>&#x000a0;This might have contributed to the low rate of hypermyoglobinemia in this group of patients. Edwards et al. also found that measurement of myoglobin offered no advantage over CK for investigating any aspect of Duchenne muscular dystrophy. However, serum myoglobin measurements were helpful in detecting Duchenne muscular dystrophy carriers when used with CK and hemopexin.<xref ref-type="bibr" rid="article-28928.r69">[69]</xref></p>
        <p>Myoglobin measurements are also used for the diagnosis of patients with rhabdomyolysis.<xref ref-type="bibr" rid="article-28928.r7">[7]</xref>&#x000a0;The course and clinical presentation of rhabdomyolysis can vary significantly depending on the cause of the muscle injury.&#x000a0;Symptoms may be localized to one specific area or diffusely affect the entire body. Complications may occur at varying stages of muscle injury.<xref ref-type="bibr" rid="article-28928.r26">[26]</xref> The classic triad of symptoms associated with rhabdomyolysis includes muscle pain, especially in the shoulders, lower back, or thighs; muscle weakness; and darkened brownish urine or decreased urine output.<xref ref-type="bibr" rid="article-28928.r25">[25]</xref>&#x000a0;Approximately 50% of individuals who experience rhabdomyolysis may present asymptomatically.<xref ref-type="bibr" rid="article-28928.r27">[27]</xref></p>
        <p>Other symptoms seen with rhabdomyolysis include nausea, vomiting, abdominal pain, tachycardia, fever or chills, dehydration, confusion, or an altered level of consciousness which may present as a coma.<xref ref-type="bibr" rid="article-28928.r70">[70]</xref> Severe complications due to rhabdomyolysis are more frequently encountered in patients who are dehydrated.<xref ref-type="bibr" rid="article-28928.r71">[71]</xref>&#x000a0;Elevated potassium in the blood due to muscle cell damage may result in cardiac arrhythmias or even cardiac arrest and death.<xref ref-type="bibr" rid="article-28928.r28">[28]</xref> Serum uric acid may increase,&#x000a0;and metabolic acidosis may occur due to acute kidney injury secondary to myoglobinuria.&#x000a0;Kidney injury may lead to elevated creatinine and blood urea nitrogen levels, in&#x000a0;addition to an increase in creatinine leaking into the blood from the damaged muscle cells themselves.<xref ref-type="bibr" rid="article-28928.r30">[30]</xref></p>
        <p>Although myoglobin is easily filtered by the glomerulus and rapidly excreted into the urine in health, it is important to recognize the presence and severity of myoglobinuria and intervene as early as possible. Aggressive hydration or alkalinization of urine may facilitate the excretion of myoglobin and prevent acute kidney injury.<xref ref-type="bibr" rid="article-28928.r72">[72]</xref>&#x000a0;Myoglobinuria is often associated with darkened, brown, or tea-colored urine and decreased urine output.<xref ref-type="bibr" rid="article-28928.r8">[8]</xref> However, it is essential to distinguish myoglobinuria from hematuria. Where myoglobinuria produces more brownish-colored urine and only a&#x000a0;few red blood cells per high-power field on urinalysis, hematuria&#x000a0;often&#x000a0;will cause reddish urine and many red blood cells on urinalysis.<xref ref-type="bibr" rid="article-28928.r9">[9]</xref> The creatine kinase level will be much higher in patients with myoglobinuria than in those with hematuria.<xref ref-type="bibr" rid="article-28928.r71">[71]</xref></p>
      </sec>
      <sec id="article-28928.s9" sec-type="Quality Control and Lab Safety&#x0000d;&#x0000a;">
        <title>Quality Control and Lab Safety
</title>
        <p>For non-waived tests, laboratory regulations require, at the minimum, analysis of at least two levels of control materials once every 24 hours.<xref ref-type="bibr" rid="article-28928.r73">[73]</xref> Laboratories can assay QC samples more frequently to ensure accurate results. Quality control samples should be assayed after calibration or maintenance of an analyzer to verify the correct method performance.<xref ref-type="bibr" rid="article-28928.r74">[74]</xref>&#x000a0;To minimize QC when performing tests for which manufacturers&#x02019; recommendations are less than those required by the regulatory agency (such as once per month), the labs can develop an individualized quality control plan (IQCP) that involves performing a risk assessment of potential sources of error in all phases of testing and putting in place a QC plan to reduce the likelihood of errors.<xref ref-type="bibr" rid="article-28928.r75">[75]</xref>&#x000a0;Westgard multi-rules are used to evaluate the quality control runs. In case of any rule violation, proper corrective and preventive action should be taken before patient testing is performed.<xref ref-type="bibr" rid="article-28928.r76">[76]</xref></p>
        <p>The laboratory must participate in the external quality control or proficiency testing (PT) program because it is a regulatory requirement published by the Centers for Medicare and Medicaid Services (CMS) in the Clinical Laboratory Improvement Amendments (CLIA) regulations.<xref ref-type="bibr" rid="article-28928.r77">[77]</xref>&#x000a0;It is helpful&#x000a0;to ensure the accuracy and reliability of the laboratory with regard to other laboratories performing the same or comparable assays.&#x000a0;Required participation and scored results are monitored by CMS and voluntary accreditation organizations.<xref ref-type="bibr" rid="article-28928.r78">[78]</xref>&#x000a0;The PT plan should be included as an aspect of the quality assessment (QA) plan and the overall quality program of the laboratory.<xref ref-type="bibr" rid="article-28928.r79">[79]</xref></p>
        <p>Consider all specimens, control materials, and calibrator materials as potentially infectious. Exercise the normal precautions required for handling all laboratory reagents. Disposal of all waste material should be in accordance with local guidelines.<xref ref-type="bibr" rid="article-28928.r80">[80]</xref> Wear gloves, a lab coat, and safety glasses when handling human blood specimens. Place all plastic tips, sample cups, and gloves that come into contact with blood in a biohazard waste container.&#x000a0;Discard all disposable glassware into sharps waste containers.<xref ref-type="bibr" rid="article-28928.r81">[81]</xref> Protect all work surfaces with disposable absorbent bench top paper, discarded into biohazard waste containers weekly or whenever blood contamination occurs. Wipe all work surfaces weekly.<xref ref-type="bibr" rid="article-28928.r82">[82]</xref></p>
      </sec>
      <sec id="article-28928.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28928&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28928">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28928/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28928">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28928.s11">
        <title>References</title>
        <ref id="article-28928.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ordway</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Garry</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Myoglobin: an essential hemoprotein in striated muscle.</article-title>
            <source>J Exp Biol</source>
            <year>2004</year>
            <month>Sep</month>
            <volume>207</volume>
            <issue>Pt 20</issue>
            <fpage>3441</fpage>
            <page-range>3441-6</page-range>
            <pub-id pub-id-type="pmid">15339940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hendgen-Cotta</surname>
                <given-names>UB</given-names>
              </name>
              <name>
                <surname>Fl&#x000f6;gel</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kelm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rassaf</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Unmasking the Janus face of myoglobin in health and disease.</article-title>
            <source>J Exp Biol</source>
            <year>2010</year>
            <month>Aug</month>
            <day>15</day>
            <volume>213</volume>
            <issue>Pt 16</issue>
            <fpage>2734</fpage>
            <page-range>2734-40</page-range>
            <pub-id pub-id-type="pmid">20675542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuzmanovska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cvetkovska</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kuzmanovski</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jankulovski</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shosholcheva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kartalov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spirovska</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis in Critically Ill Surgical Patients.</article-title>
            <source>Med Arch</source>
            <year>2016</year>
            <month>Jul</month>
            <day>27</day>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>308</fpage>
            <page-range>308-310</page-range>
            <pub-id pub-id-type="pmid">27703296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giuliani</surname>
                <given-names>KTK</given-names>
              </name>
              <name>
                <surname>Kassianos</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Healy</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gois</surname>
                <given-names>PHF</given-names>
              </name>
            </person-group>
            <article-title>Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Apr</month>
            <day>23</day>
            <volume>20</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">31018590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aydin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ugur</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>&#x00130;</given-names>
              </name>
              <name>
                <surname>Yardim</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Biomarkers in acute myocardial infarction: current perspectives.</article-title>
            <source>Vasc Health Risk Manag</source>
            <year>2019</year>
            <volume>15</volume>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">30697054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nilsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alkner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wetterl&#x000f6;v</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wetterstad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Palm</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schilcher</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Low compartment pressure and myoglobin levels in tibial fractures with suspected acute compartment syndrome.</article-title>
            <source>BMC Musculoskelet Disord</source>
            <year>2019</year>
            <month>Jan</month>
            <day>05</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <pub-id pub-id-type="pmid">30611244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cabral</surname>
                <given-names>BMI</given-names>
              </name>
              <name>
                <surname>Edding</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Portocarrero</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Lerma</surname>
                <given-names>EV</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis.</article-title>
            <source>Dis Mon</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>66</volume>
            <issue>8</issue>
            <fpage>101015</fpage>
            <pub-id pub-id-type="pmid">32532456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>David</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Myoglobinuria.</article-title>
            <source>Neurol Clin</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>215</fpage>
            <page-range>215-43</page-range>
            <pub-id pub-id-type="pmid">10658177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oishi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kira</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Myoglobinuria].</article-title>
            <source>Ryoikibetsu Shokogun Shirizu</source>
            <year>2001</year>
            <issue>35</issue>
            <fpage>189</fpage>
            <page-range>189-91</page-range>
            <pub-id pub-id-type="pmid">11555907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tein</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>DiMauro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>DeVivo</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Recurrent childhood myoglobinuria.</article-title>
            <source>Adv Pediatr</source>
            <year>1990</year>
            <volume>37</volume>
            <fpage>77</fpage>
            <page-range>77-117</page-range>
            <pub-id pub-id-type="pmid">2264536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Servonnet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dubost</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lefr&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fontan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ceppa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Delacour</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Myoglobin: still a useful biomarker in 2017?].</article-title>
            <source>Ann Biol Clin (Paris)</source>
            <year>2018</year>
            <month>Apr</month>
            <day>01</day>
            <volume>76</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-141</page-range>
            <pub-id pub-id-type="pmid">29623882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stopp</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Feichtinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eppel</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Stulnig</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Husslein</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>G&#x000f6;bl</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Pre- and peripartal management of a woman with McArdle disease: a case report.</article-title>
            <source>Gynecol Endocrinol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>9</issue>
            <fpage>736</fpage>
            <page-range>736-739</page-range>
            <pub-id pub-id-type="pmid">29560763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r13">
          <label>13</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Stanley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chippa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aeddula</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Quintanilla Rodriguez</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Adigun</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <chapter-title>Rhabdomyolysis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">28846335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conley</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Ordway</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Deciphering the mysteries of myoglobin in striated muscle.</article-title>
            <source>Acta Physiol Scand</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>168</volume>
            <issue>4</issue>
            <fpage>623</fpage>
            <page-range>623-34</page-range>
            <pub-id pub-id-type="pmid">10759599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ono-Moore</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Olfert</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Rutkowsky</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Chintapalli</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Willis</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Blackburn</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>O'Reilly</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tolentino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>KCK</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Metabolic physiology and skeletal muscle phenotypes in male and female myoglobin knockout mice.</article-title>
            <source>Am J Physiol Endocrinol Metab</source>
            <year>2021</year>
            <month>Jul</month>
            <day>01</day>
            <volume>321</volume>
            <issue>1</issue>
            <fpage>E63</fpage>
            <page-range>E63-E79</page-range>
            <pub-id pub-id-type="pmid">33969704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sylv&#x000e9;n</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jansson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>B&#x000f6;&#x000f6;k</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Myoglobin content in human skeletal muscle and myocardium: relation to fibre size and oxidative capacity.</article-title>
            <source>Cardiovasc Res</source>
            <year>1984</year>
            <month>Jul</month>
            <volume>18</volume>
            <issue>7</issue>
            <fpage>443</fpage>
            <page-range>443-6</page-range>
            <pub-id pub-id-type="pmid">6744365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Capote</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Balion</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Cleve</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>El Sharif</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Utility of urine myoglobin for the prediction of acute renal failure in patients with suspected rhabdomyolysis: a systematic review.</article-title>
            <source>Clin Chem</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>55</volume>
            <issue>12</issue>
            <fpage>2190</fpage>
            <page-range>2190-7</page-range>
            <pub-id pub-id-type="pmid">19797717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moreno</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n-Cleary</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guti&#x000e9;rrez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Toldos</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Blanco-Colio</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Praga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ortiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Egido</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <page-range>175-84</page-range>
            <pub-id pub-id-type="pmid">22096039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;n Cleary</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ortiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parra</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Gracia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Blanco-Colio</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Barat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Egido</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Glomerular haematuria, renal interstitial haemorrhage and acute kidney injury.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>12</issue>
            <fpage>4103</fpage>
            <page-range>4103-6</page-range>
            <pub-id pub-id-type="pmid">20709744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pagani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bonetti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Stefini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cuccia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Panteghini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Serum and plasma samples for ACS:systems cardiac markers.</article-title>
            <source>Clin Chem</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>7</issue>
            <fpage>1020</fpage>
            <page-range>1020-2</page-range>
            <pub-id pub-id-type="pmid">10894856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaninotto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pagani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Altinier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amboni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bonora</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dolci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pergolini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vernocchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Panteghini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Multicenter evaluation of five assays for myoglobin determination.</article-title>
            <source>Clin Chem</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>46</volume>
            <issue>10</issue>
            <fpage>1631</fpage>
            <page-range>1631-7</page-range>
            <pub-id pub-id-type="pmid">11017942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carraro</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Varagnolo</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Zaninotto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rossetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burlina</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A new immunoassay for the measurement of myoglobin in serum.</article-title>
            <source>J Clin Lab Anal</source>
            <year>1994</year>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>70</fpage>
            <page-range>70-5</page-range>
            <pub-id pub-id-type="pmid">8189324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Laios</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gornet</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Parmley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tonnesen</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Plaisier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Orlando</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure.</article-title>
            <source>Clin Chem</source>
            <year>1994</year>
            <month>May</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>796</fpage>
            <page-range>796-802</page-range>
            <pub-id pub-id-type="pmid">8174254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loun</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Astles</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Copeland</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Sedor</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Adaptation of a quantitative immunoassay for urine myoglobin. Predictor in detecting renal dysfunction.</article-title>
            <source>Am J Clin Pathol</source>
            <year>1996</year>
            <month>Apr</month>
            <volume>105</volume>
            <issue>4</issue>
            <fpage>479</fpage>
            <page-range>479-86</page-range>
            <pub-id pub-id-type="pmid">8604691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thorson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Penmatsa</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis: Revisited.</article-title>
            <source>Ulster Med J</source>
            <year>2021</year>
            <month>May</month>
            <volume>90</volume>
            <issue>2</issue>
            <fpage>61</fpage>
            <page-range>61-69</page-range>
            <pub-id pub-id-type="pmid">34276082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baeza-Trinidad</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis: A syndrome to be considered.</article-title>
            <source>Med Clin (Barc)</source>
            <year>2022</year>
            <month>Mar</month>
            <day>25</day>
            <volume>158</volume>
            <issue>6</issue>
            <fpage>277</fpage>
            <page-range>277-283</page-range>
            <pub-id pub-id-type="pmid">34872769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zimmerman</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis.</article-title>
            <source>Chest</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>144</volume>
            <issue>3</issue>
            <fpage>1058</fpage>
            <page-range>1058-1065</page-range>
            <pub-id pub-id-type="pmid">24008958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nance</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Mammen</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic evaluation of rhabdomyolysis.</article-title>
            <source>Muscle Nerve</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>793</fpage>
            <page-range>793-810</page-range>
            <pub-id pub-id-type="pmid">25678154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zutt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van der Kooi</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Linthorst</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Wanders</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>de Visser</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis: review of the literature.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>651</fpage>
            <page-range>651-9</page-range>
            <pub-id pub-id-type="pmid">24946698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petejova</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Martinek</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review.</article-title>
            <source>Crit Care</source>
            <year>2014</year>
            <month>May</month>
            <day>28</day>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>224</fpage>
            <pub-id pub-id-type="pmid">25043142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shipley</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Wrye</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Myoglobinuria.</article-title>
            <source>Heart Lung</source>
            <year>1976</year>
            <season>Nov-Dec</season>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>950</fpage>
            <page-range>950-4</page-range>
            <pub-id pub-id-type="pmid">1049218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zierz</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[Rhabdomyolysis and myoglobinuria].</article-title>
            <source>Nervenarzt</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>74</volume>
            <issue>6</issue>
            <fpage>505</fpage>
            <page-range>505-15</page-range>
            <pub-id pub-id-type="pmid">12799789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apple</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Voss</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Preese</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapy.</article-title>
            <source>Clin Chim Acta</source>
            <year>1995</year>
            <month>Jun</month>
            <day>15</day>
            <volume>237</volume>
            <issue>1-2</issue>
            <fpage>59</fpage>
            <page-range>59-66</page-range>
            <pub-id pub-id-type="pmid">7664479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schifman</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Luevano</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Value and Use of Urinalysis for Myoglobinuria.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>143</volume>
            <issue>11</issue>
            <fpage>1378</fpage>
            <page-range>1378-1381</page-range>
            <pub-id pub-id-type="pmid">31116043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alavi-Moghaddam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Safari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Najafi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hosseini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of urine dipstick in the detection of patients at risk for crush-induced rhabdomyolysis and acute kidney injury.</article-title>
            <source>Eur J Emerg Med</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>329</fpage>
            <page-range>329-32</page-range>
            <pub-id pub-id-type="pmid">22082877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cervellin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Comelli</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Benatti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sanchis-Gomar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bassi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Non-traumatic rhabdomyolysis: Background, laboratory features, and acute clinical management.</article-title>
            <source>Clin Biochem</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>50</volume>
            <issue>12</issue>
            <fpage>656</fpage>
            <page-range>656-662</page-range>
            <pub-id pub-id-type="pmid">28235546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mian</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis of the head and neck: computed tomography and magnetic resonance imaging findings.</article-title>
            <source>Dentomaxillofac Radiol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>390</fpage>
            <page-range>390-2</page-range>
            <pub-id pub-id-type="pmid">21831980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keltz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis. The role of diagnostic and prognostic factors.</article-title>
            <source>Muscles Ligaments Tendons J</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>303</fpage>
            <page-range>303-12</page-range>
            <pub-id pub-id-type="pmid">24596694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hibrawi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Garrison</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>A comparison of various agarose preparations in a counter--immunoelectrophoresis (CIE) system for assaying urinary myoglobin.</article-title>
            <source>J Immunol Methods</source>
            <year>1977</year>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-63</page-range>
            <pub-id pub-id-type="pmid">833429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Motegi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ohki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hokari</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hiramori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sumiyoshi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kimata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hirosawa</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Serum myoglobin detection by counterimmunoelectrophoresis using a dextran-supplemented agarose plate: method and application to acute myocardial infarction diagnosis (author's transl)].</article-title>
            <source>Rinsho Byori</source>
            <year>1978</year>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>235</fpage>
            <page-range>235-9</page-range>
            <pub-id pub-id-type="pmid">650953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cloonan</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Donald</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Neale</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wilcken</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>The detection of myoglobin in urine and its application to the diagnosis of myocardial infarction.</article-title>
            <source>Pathology</source>
            <year>1976</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>313</fpage>
            <page-range>313-20</page-range>
            <pub-id pub-id-type="pmid">1018950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>N&#x000f8;rregaard-Hansen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hangaard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>N&#x000f8;rgaard-Pedersen</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>A rapid latex agglutination test for detection of elevated levels of myoglobin in serum and its value in the early diagnosis of acute myocardial infarction.</article-title>
            <source>Scand J Clin Lab Invest</source>
            <year>1984</year>
            <month>Apr</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <page-range>99-103</page-range>
            <pub-id pub-id-type="pmid">6719025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hangaard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>N&#x000f8;rregaard-Hansen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>J&#x000f8;rgensen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Simonsen</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>N&#x000f8;rgaard-Pedersen</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Early diagnosis of acute myocardial infarction with a rapid latex agglutination test for semi-quantitative estimation of serum myoglobin.</article-title>
            <source>Acta Med Scand</source>
            <year>1987</year>
            <volume>221</volume>
            <issue>4</issue>
            <fpage>343</fpage>
            <page-range>343-8</page-range>
            <pub-id pub-id-type="pmid">3604750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapelle</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Heusghem</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Semi-quantitative estimation of serum myoglobin by a rapid latex agglutination method: an emergency screening test for acute myocardial infarction.</article-title>
            <source>Clin Chim Acta</source>
            <year>1985</year>
            <month>Jan</month>
            <day>30</day>
            <volume>145</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-50</page-range>
            <pub-id pub-id-type="pmid">3971587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>NZ</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>YQ</given-names>
              </name>
            </person-group>
            <article-title>[Semi-quantitative estimation of serum myoglobin with rapid reverse passive latex agglutination (RPLA) test and its application in the early diagnosis of acute myocardial infarction].</article-title>
            <source>Zhonghua Nei Ke Za Zhi</source>
            <year>1990</year>
            <month>May</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>280</fpage>
            <page-range>280-2, 316</page-range>
            <pub-id pub-id-type="pmid">2242688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kagen</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Myoglobin: methods and diagnostic uses.</article-title>
            <source>CRC Crit Rev Clin Lab Sci</source>
            <year>1978</year>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>273</fpage>
            <page-range>273-302</page-range>
            <pub-id pub-id-type="pmid">401372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dombrovski&#x0012d;</surname>
                <given-names>VI</given-names>
              </name>
              <name>
                <surname>Staroverov</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Rott</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Poverenny&#x0012d;</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tsyb</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>[Immunochemical methods of determining myoglobin in blood and urine].</article-title>
            <source>Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR</source>
            <year>1981</year>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>88</fpage>
            <page-range>88-94</page-range>
            <pub-id pub-id-type="pmid">7259874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyoshi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kawai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iwasa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yagita</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Radioimmunoassay for human myoglobin: methods and results in patients with skeletal muscle or myocardial disorders.</article-title>
            <source>J Lab Clin Med</source>
            <year>1978</year>
            <month>Sep</month>
            <volume>92</volume>
            <issue>3</issue>
            <fpage>341</fpage>
            <page-range>341-52</page-range>
            <pub-id pub-id-type="pmid">681820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matveeva</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gryczynski</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Gryczynski</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Malicka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lakowicz</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Myoglobin immunoassay utilizing directional surface plasmon-coupled emission.</article-title>
            <source>Anal Chem</source>
            <year>2004</year>
            <month>Nov</month>
            <day>01</day>
            <volume>76</volume>
            <issue>21</issue>
            <fpage>6287</fpage>
            <page-range>6287-92</page-range>
            <pub-id pub-id-type="pmid">15516120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Willerson</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Gomez-Sanchez</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Waterman</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction.</article-title>
            <source>J Clin Invest</source>
            <year>1975</year>
            <month>Nov</month>
            <volume>56</volume>
            <issue>5</issue>
            <fpage>1334</fpage>
            <page-range>1334-9</page-range>
            <pub-id pub-id-type="pmid">1184754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matveeva</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Gryczynski</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lakowicz</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Myoglobin immunoassay based on metal particle-enhanced fluorescence.</article-title>
            <source>J Immunol Methods</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>302</volume>
            <issue>1-2</issue>
            <fpage>26</fpage>
            <page-range>26-35</page-range>
            <pub-id pub-id-type="pmid">15996681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kottwitz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Salomon</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Fairweather</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Elhassan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baltensperger</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kissel</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Lovrinovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baltensweiler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schmied</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Templin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>JAC</given-names>
              </name>
              <name>
                <surname>Landmesser</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>L&#x000fc;scher</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Manka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heidecker</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Myoglobin for Detection of High-Risk Patients with Acute Myocarditis.</article-title>
            <source>J Cardiovasc Transl Res</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>853</fpage>
            <page-range>853-863</page-range>
            <pub-id pub-id-type="pmid">32006209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Mok</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>Point-of-care fluorescence immunoassay for cardiac panel biomarkers.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>419</fpage>
            <page-range>419-27</page-range>
            <pub-id pub-id-type="pmid">24652617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hudson</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Christenson</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Newby</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Ohman</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Cardiac markers: point of care testing.</article-title>
            <source>Clin Chim Acta</source>
            <year>1999</year>
            <month>Jun</month>
            <day>30</day>
            <volume>284</volume>
            <issue>2</issue>
            <fpage>223</fpage>
            <page-range>223-37</page-range>
            <pub-id pub-id-type="pmid">10451248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Fei</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>National survey on turnaround time of clinical biochemistry tests in 738 laboratories in China.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28493522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wlaze&#x00142;</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Kasprzak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Paradowski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A new generation of biomarkers tests of myocardial necrosis: the real quality a physician can get from the laboratory.</article-title>
            <source>Med Sci Monit</source>
            <year>2015</year>
            <month>Jan</month>
            <day>28</day>
            <volume>21</volume>
            <fpage>338</fpage>
            <page-range>338-44</page-range>
            <pub-id pub-id-type="pmid">25629263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Males</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Stephenson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Cardiac markers and point-of-care testing: a perfect fit.</article-title>
            <source>Crit Care Nurs Q</source>
            <year>2001</year>
            <month>May</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-61</page-range>
            <pub-id pub-id-type="pmid">11868696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakker</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Boymans</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Dijkstra</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gorgels</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Lerk</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Rapid determination of serum myoglobin with a routine chemistry analyzer.</article-title>
            <source>Clin Chem</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>653</fpage>
            <page-range>653-8</page-range>
            <pub-id pub-id-type="pmid">8472361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Serum myoglobin immunoassays: obsolete or still clinically useful?</article-title>
            <source>Clin Chem Lab Med</source>
            <year>2016</year>
            <month>Oct</month>
            <day>01</day>
            <volume>54</volume>
            <issue>10</issue>
            <fpage>1541</fpage>
            <page-range>1541-3</page-range>
            <pub-id pub-id-type="pmid">27341565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berenbrink</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Myoglobin's old and new clothes: from molecular structure to integrated function and evolution.</article-title>
            <source>J Exp Biol</source>
            <year>2010</year>
            <month>Aug</month>
            <day>15</day>
            <volume>213</volume>
            <issue>Pt 16</issue>
            <fpage>2711</fpage>
            <page-range>2711-2</page-range>
            <pub-id pub-id-type="pmid">20675539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction.</article-title>
            <source>Clin Lab</source>
            <year>2017</year>
            <month>Mar</month>
            <day>01</day>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>427</fpage>
            <page-range>427-433</page-range>
            <pub-id pub-id-type="pmid">28271683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montague</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kircher</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Myoglobin in the early evaluation of acute chest pain.</article-title>
            <source>Am J Clin Pathol</source>
            <year>1995</year>
            <month>Oct</month>
            <volume>104</volume>
            <issue>4</issue>
            <fpage>472</fpage>
            <page-range>472-6</page-range>
            <pub-id pub-id-type="pmid">7572801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lacbawan</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Sunheimer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>LeFever</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McCabe</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting?</article-title>
            <source>Am J Clin Pathol</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>725</fpage>
            <page-range>725-9</page-range>
            <pub-id pub-id-type="pmid">7785657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasi&#x00107;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jadri&#x00107;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kiseljakovi&#x00107;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Radovanovi&#x00107;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Winterhalter-Jadri&#x00107;</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Comparison of creatine kinase activity and myoglobin blood level in acute myocardial infarction patients.</article-title>
            <source>Bosn J Basic Med Sci</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-23</page-range>
            <pub-id pub-id-type="pmid">16533174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheffold</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zehelein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller-Bardorff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Katus</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>[Monitoring ischemia with new markers].</article-title>
            <source>Z Kardiol</source>
            <year>1994</year>
            <volume>83 Suppl 6</volume>
            <fpage>75</fpage>
            <page-range>75-82</page-range>
            <pub-id pub-id-type="pmid">7863704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Askmark</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Osterman</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Roxin</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Venge</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Radioimmunoassay of serum myoglobin in neuromuscular diseases.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1981</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-72</page-range>
            <pub-id pub-id-type="pmid">7205308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Percy</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Pichora</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Manchester</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.</article-title>
            <source>Am J Med Genet</source>
            <year>1984</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>279</fpage>
            <page-range>279-87</page-range>
            <pub-id pub-id-type="pmid">6465202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliv&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Engvall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ravenscroft</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cabrera-Serrano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jiao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bortolotti</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Pignataro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lambrughi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Forrest</surname>
                <given-names>ARR</given-names>
              </name>
              <name>
                <surname>Benseny-Cases</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hofbauer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Obinger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Battistuzzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bellei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borsari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Rocco</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Viola</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Hool</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Cladera</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lagerstedt-Robinson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wredenberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miralles</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baiges</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Malfatti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Streichenberger</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vial</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Claeys</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Straathof</surname>
                <given-names>CSM</given-names>
              </name>
              <name>
                <surname>Goris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Freyer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lammens</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bassez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kere</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Clemente</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sejersen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Udd</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vidal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Edstr&#x000f6;m</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wedell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laing</surname>
                <given-names>NG</given-names>
              </name>
            </person-group>
            <article-title>Myoglobinopathy is an adult-onset autosomal dominant myopathy with characteristic sarcoplasmic inclusions.</article-title>
            <source>Nat Commun</source>
            <year>2019</year>
            <month>Mar</month>
            <day>27</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>1396</fpage>
            <pub-id pub-id-type="pmid">30918256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edwards</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Rodeck</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>The diagnostic value of plasma myoglobin levels in the adult and fetus at-risk for Duchenne muscular dystrophy.</article-title>
            <source>J Neurol Sci</source>
            <year>1984</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>173</fpage>
            <page-range>173-82</page-range>
            <pub-id pub-id-type="pmid">6707690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosch</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Poch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grau</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis and acute kidney injury.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Jul</month>
            <day>02</day>
            <volume>361</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-72</page-range>
            <pub-id pub-id-type="pmid">19571284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>FY</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis: a review of the literature.</article-title>
            <source>Neth J Med</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>67</volume>
            <issue>9</issue>
            <fpage>272</fpage>
            <page-range>272-83</page-range>
            <pub-id pub-id-type="pmid">19841484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamal</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Snook</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saikumar</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis-Associated Acute Kidney Injury With Normal Creatine Phosphokinase.</article-title>
            <source>Am J Med Sci</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>355</volume>
            <issue>1</issue>
            <fpage>84</fpage>
            <page-range>84-87</page-range>
            <pub-id pub-id-type="pmid">29289268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kearney</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control.</article-title>
            <source>Methods Mol Biol</source>
            <year>2013</year>
            <volume>1065</volume>
            <fpage>277</fpage>
            <page-range>277-89</page-range>
            <pub-id pub-id-type="pmid">23996371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kinns</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pitkin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Housley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control: best practice.</article-title>
            <source>J Clin Pathol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>66</volume>
            <issue>12</issue>
            <fpage>1027</fpage>
            <page-range>1027-32</page-range>
            <pub-id pub-id-type="pmid">24072731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruno</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>IQCP: Guideline and Helpful Tools for Implementation.</article-title>
            <source>Lab Med</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>e42</fpage>
            <page-range>e42-e46</page-range>
            <pub-id pub-id-type="pmid">27708173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poh</surname>
                <given-names>DKH</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>RZ</given-names>
              </name>
              <name>
                <surname>Markus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Loh</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Internal quality control: Moving average algorithms outperform Westgard rules.</article-title>
            <source>Clin Biochem</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>98</volume>
            <fpage>63</fpage>
            <page-range>63-69</page-range>
            <pub-id pub-id-type="pmid">34534518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prier</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sideman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yankevitch</surname>
                <given-names>IJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical laboratory proficiency testing.</article-title>
            <source>Health Lab Sci</source>
            <year>1968</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-8</page-range>
            <pub-id pub-id-type="pmid">5637121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartola</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The importance of an effective proficiency testing program to the regulation of clinical laboratories. The view from one state.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>112</volume>
            <issue>4</issue>
            <fpage>368</fpage>
            <page-range>368-70</page-range>
            <pub-id pub-id-type="pmid">3128246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abu-Amero</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Overview of the laboratory accreditation programme of the College of American Pathologists.</article-title>
            <source>East Mediterr Health J</source>
            <year>2002</year>
            <season>Jul-Sep</season>
            <volume>8</volume>
            <issue>4-5</issue>
            <fpage>654</fpage>
            <page-range>654-63</page-range>
            <pub-id pub-id-type="pmid">15603049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cornish</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Arambula</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Arduino</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Giri</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Pentella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Salerno</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Sandhu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Tormey</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Wagar</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Weirich</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2021</year>
            <month>Jun</month>
            <day>16</day>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>e0012618</fpage>
            <pub-id pub-id-type="pmid">34105993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Bellis</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Pullman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shultz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Building Biosafety Capacity in Our Nation's Laboratories.</article-title>
            <source>Health Secur</source>
            <year>2019</year>
            <season>Sep/Oct</season>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>353</fpage>
            <page-range>353-363</page-range>
            <pub-id pub-id-type="pmid">31593513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28928.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pentella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory.</article-title>
            <source>Clin Lab Med</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>473</fpage>
            <page-range>473-482</page-range>
            <pub-id pub-id-type="pmid">33121616</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
